References
- Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, et al. Multidrug-resistant and extensively drugresistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010;375:1830-43. https://doi.org/10.1016/S0140-6736(10)60410-2
- Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011;38:516-28. https://doi.org/10.1183/09031936.00073611
- World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2006.361. Geneva: WHO; 2006.
- Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2010. Atlanta: Centers for Disease Control and Prevention; 2011.
- Daikos GL, Uttamchandani RB, Tuda C, Fischl MA, Miller N, Cleary T, et al. Disseminated miliary tuberculosis of the skin in patients with AIDS: report of four cases. Clin Infect Dis 1998;27:205-8. https://doi.org/10.1086/514608
- Hill AR, Premkumar S, Brustein S, Vaidya K, Powell S, Li PW, et al. Disseminated tuberculosis in the acquired immunodeficiency syndrome era. Am Rev Respir Dis 1991;144:1164-70. https://doi.org/10.1164/ajrccm/144.5.1164
- Shah A, Panjabi C, Maurya V, Khanna P. Multidrug resistant miliary tuberculosis and Pott's disease in an immunocompetent patient. Saudi Med J 2004;25:1468-70.
- Sasse J, Teichmann D. Disseminated multiorgan MDRTB resistant to virtually all first-line drugs. Eur Respir Rev 2009;18:291-4. https://doi.org/10.1183/09059180.00002109
- Kim SY, Kim HJ, Kim CK, Yoon HR, Bae HG, Lee SH, et al. The recent status of multidrug- and extensively drug-resistant tuberculosis in Korea. Tuberc Respir Dis 2010;68:146-54. https://doi.org/10.4046/trd.2010.68.3.146
- Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis 2010;14:382-90.
- Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis 1990;12:583-90. https://doi.org/10.1093/clinids/12.4.583
- Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N. Diagnosis and management of miliary tuberculosis: current state and future perspectives. Ther Clin Risk Manag 2013;9:9-26.
- Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 2009;103:1777-90. https://doi.org/10.1016/j.rmed.2009.07.010
- Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and metaanalysis. BMC Infect Dis 2005;5:62. https://doi.org/10.1186/1471-2334-5-62
- Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009;9:67. https://doi.org/10.1186/1471-2334-9-67
Cited by
- Diagnostic usefulness of the GenoType MTBDRplusassay for detecting drug-resistant tuberculosis using AFB smear-negative specimens with positive TB-PCR result vol.48, pp.5, 2016, https://doi.org/10.3109/23744235.2015.1122831
- An Unusual Case of Multidrug Resistant Miliary Tuberculosis vol.11, pp.4, 2014, https://doi.org/10.5812/archcid.37805
- First Use of Bedaquiline in Democratic Republic of Congo: Two Case Series of Pre Extensively Drug Resistant Tuberculosis vol.6, pp.2, 2014, https://doi.org/10.4236/jtr.2018.62012